ad

Metropolis Healthcare Q4 FY26 Results: Consolidated PAT Rs 50.90 Crore 2nd Interim Dividend Declared

14 May 20264:18 pm

Metropolis Healthcare Q4 FY26 Results: Consolidated PAT Rs 50.90 Crore 2nd Interim Dividend Declared

Metropolis Healthcare Q4 FY26 results were announced on 13 May 2026. Metropolis Healthcare Q4 FY26 consolidated PAT was Rs 50.90 crore. The company, one of India's largest diagnostics chains, declared a 2nd interim dividend for FY26 at its Q4 board meeting. Metropolis Healthcare operates a network of diagnostic labs and collection centres across India, serving patients and hospitals. Investors tracking Metropolis Healthcare Q4 FY26 results will find detailed financial data, analysis, and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

Metropolis Healthcare Q4 FY26 Key Financial Highlights

Parameter Q4 FY26 Reference
Net Profit (PAT) Rs 50.90 crore Reference period
Dividend Rs 2nd interim declared per share Subject to AGM approval
NSE Ticker METROPOLIS Sector: Diagnostic Services

Screen the best stocks on the Univest Screener.

Metropolis Healthcare Q4 FY26 Performance Analysis

Metropolis Healthcare Q4 FY26 consolidated PAT was Rs 50.90 crore. The company, one of India's largest diagnostics chains, declared a 2nd interim dividend for FY26 at its Q4 board meeting. Metropolis Healthcare operates a network of diagnostic labs and collection centres across India, serving patients and hospitals. Investors and analysts will closely monitor management commentary on FY27 revenue outlook, margin trajectory, and capital allocation strategy following these Metropolis Healthcare Q4 FY26 results.

The Metropolis Healthcare Q4 FY26 results represent a strong growth quarter for the company. Track live price, analyst ratings, and earnings updates on the Univest Screener.

Metropolis Healthcare FY27 Outlook

Post Metropolis Healthcare Q4 FY26 results, investor focus for FY27 will be on management guidance, margin trajectory, new order wins or business development, and sector-specific tailwinds. The strong Q4 FY26 performance sets a positive base for FY27 earnings delivery.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on Metropolis Healthcare Q4 FY26 Results

What is Metropolis Healthcare Q4 FY26 net profit?

Ans. Metropolis Healthcare Q4 FY26 net profit is Rs 50.90 crore.

When did Metropolis Healthcare announce Q4 FY26 results?

Ans. Metropolis Healthcare announced Q4 FY26 results on 13 May 2026, through its board meeting and BSE/NSE exchange filings.

What is Metropolis Healthcare Q4 FY26 dividend?

Ans. The board recommended a final dividend of Rs 2nd interim declared per equity share for FY26, subject to shareholder approval at the AGM.

Where can I track Metropolis Healthcare Q4 FY26 live data?

Ans. Track Metropolis Healthcare live price, analyst ratings, and Q4 FY26 earnings updates on the Univest Screener for real-time data and research.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. All financial data cited is sourced from BSE/NSE exchange filings and verified news sources. Investments in securities are subject to market risk. Consult a SEBI-registered investment advisor before making any investment decision.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down